Exploring the Impact of Weight Loss Drugs on Healthcare Costs

This chapter explores how weight loss drugs like Ozempic, Vigowi, and Monjaro could potentially lower healthcare costs by helping individuals manage obesity and related health issues. It highlights the rising popularity of these medications originally aimed at treating type 2 diabetes and discusses their implications for the future of healthcare in America.